Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

4.70
-0.1600-3.29%
Pre-market: 4.740.0400+0.85%06:34 EST
Volume:17.19M
Turnover:81.28M
Market Cap:2.44B
PE:-2.63
High:4.80
Open:4.80
Low:4.65
Close:4.86
52wk High:12.36
52wk Low:3.79
Shares:519.84M
Float Shares:415.00M
Volume Ratio:0.82
T/O Rate:4.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7839
EPS(LYR):-1.6909
ROE:-91.06%
ROA:-42.04%
PB:2.33
PE(LYR):-2.78

Loading ...

Jan 06, 2026

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS' Director B. Borgeson proposes to sell 220,000 shares, with a total value of approximately $959.2K.
Jan 05, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Director Gibson Christopher proposes to sell 40,000 Shares, with a total value of approximately $170,000.
Dec 29, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Taylor Ben R proposes to sell 21,383 shares, with a total value of approximately $89K.
Dec 22, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Najat Khan proposes to sell 124,403 Shares, with a total value of approximately $548,587.96
Dec 19, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals's Officer Christopher Gibson proposes to sell 40,000 shares, with a total value of approximately $180,000.
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 04, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Christopher Gibson proposes to sell 40,000 shares, with a total value of approximately $185,200.
Dec 02, 2025

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS Director Blake Borgeson proposes to sell 220,000 shares, with a total value of approximately $961,400
Nov 26, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2025

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS' Director and Officer Gibson proposes to sell 40000 shares, with a total value of approximately $166,400.
Nov 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2025

Major Issues Report

Form 8-K - Current report
Nov 04, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Christopher Gibson proposes to sell 40,000 Shares, with a total value of approximately $208,400.
Oct 29, 2025

Major Issues Report

Form 8-K - Current report
Oct 23, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Gibson proposes to sell 100,000 shares, with a total value of approximately $570,000.
Oct 10, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Christopher Gibson proposes to sell 100,000 Shares, with a total value of approximately $604,000.
Sep 25, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Gibson proposes to sell 100,000 shares, with a total value of approximately $476,000.
Sep 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 29, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 26, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals's Officer Christopher Gibson proposes to sell 100,000 Shares, with a total value of approximately $484,000.